Neuberger Berman High Yield Strategies Fund Inc. [NHS] Stock Forecast

Neuberger Berman High Yield Strategies offers a high yield of 14.46%, higher than other closed-end funds investing in junk bonds. The NHS closed-end fund's net asset value has been declining, raising concerns about the sustainability of its distribution. The NHS fund is doing a reasonably good job at protecting itself from default risk, which seems to be increasing with interest rates.

Neuberger Berman High Yield Strategies offers a remarkable 14.25% distribution yield but has underperformed over the past year due to rising interest rates. The fund primarily invests in junk bonds and aims to provide a high level of current income to investors. The fund employs leverage to boost its yield and total investment returns, but its use of leverage could increase volatility and risk.

NHS's 2023 rights offering results are in. The offering was oversubscribed, despite the slim discount to the market price. The "sell and rebuy" strategy worked once again.

Imagine stocks or funds that pay out their dividends once-a-month! Unlike waiting for quarterly, semi-annual or (ugh) annual payouts, your angst waiting for money is reduced by 300%, or more! These May U.S. exchange-traded monthly-paid (MoPay) dividends, upsides, and net gains include: 1. Stocks by yield (83); 2. Stocks by price upside (30); 3. Closed-End Investments, Exchange-Traded Funds & Notes (CEICs/ETFs/ETNs) by yield >9.56% (80).

Quick notes on Neuberger Berman High Yield Strategies' rights offering this year. Our suggestion is to sell before the ex-rights date and rebuy after the offering.

NHS is a fixed income closed end fund. The fund focuses on U.S. high yield bonds, which represent 88% of the portfolio.

NHS is a fixed income closed end fund. Over 88% of the fund holdings are fixed rate high yield bonds.

For the first month in three, equity CEFs (+4.49%) on average witnessed plus-side returns, while their fixed income CEF cohorts (-5.07%) suffered a third month of declines in October. Only 17% of all CEFs traded at a premium to their NAV at month end, with 24% of equity CEFs and 11% of fixed income CEFs trading in premium territory.

NHS's rights offering is now live. The subscription formula has a floor of a -13% discount, at which point one should not subscribe.

NEW YORK, Sept. 30, 2021 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock.

Neuberger Berman High Yield Strategies Fund Inc. is a US stock , located in New york of Ny and trading under the symbol NHS

Neuberger Berman High Yield Strategies Fund Inc. stock price is $7.4922 today.

Yes, Neuberger Berman High Yield Strategies Fund Inc. is a publicly traded company.